Awada A - Search Results

1

A therapeutic approach to perianal extramammary Paget's disease: topical imiquimod can be useful to prevent or defer surgery.

Vereecken P, Awada A, Ghanem G, Marques da Costa C, Larsimont D, Simoens C, Mendes da Costa P, Hendlisz A. Vereecken P, et al. Among authors: awada a. Med Sci Monit. 2007 Jun;13(6):CS75-7. Med Sci Monit. 2007. PMID: 17534239

2

Management of cutaneous locoregional recurrences of melanoma: a new therapeutic perspective with imiquimod.

Vereecken P, Mathieu A, Laporte M, Petein M, Velu T, Awada A, Heenen M. Vereecken P, et al. Among authors: awada a. Dermatology. 2003;206(3):279-80. doi: 10.1159/000068901. Dermatology. 2003. PMID: 12673091 No abstract available.

3

New anticancer agents and therapeutic strategies in development for solid cancers: a clinical perspective.

Awada A, Mano M, Hendlisz A, Piccart M. Awada A, et al. Expert Rev Anticancer Ther. 2004 Feb;4(1):53-60. doi: 10.1586/14737140.4.1.53. Expert Rev Anticancer Ther. 2004. PMID: 14748657 Review.

4

Rates of topoisomerase II-alpha and HER-2 gene amplification and expression in epithelial ovarian carcinoma.

Mano MS, Awada A, Di Leo A, Durbecq V, Paesmans M, Cardoso F, Larsimont D, Piccart M. Mano MS, et al. Among authors: awada a. Gynecol Oncol. 2004 Mar;92(3):887-95. doi: 10.1016/j.ygyno.2003.12.010. Gynecol Oncol. 2004. PMID: 14984957

5

Prolonged schedule of temozolomide (Temodal) plus liposomal doxorubicin (Caelyx) in advanced solid cancers.

Awada A, Gil T, Sales F, Dubuisson M, Vereecken P, Klastersky J, Moerman C, de Valeriola D, Piccart MJ. Awada A, et al. Anticancer Drugs. 2004 Jun;15(5):499-502. doi: 10.1097/01.cad.0000127331.29310.8a. Anticancer Drugs. 2004. PMID: 15166625 Clinical Trial.

6

Expression of galectin-3 in primary and metastatic melanoma: immunohistochemical studies on human lesions and nude mice xenograft tumors.

Vereecken P, Debray C, Petein M, Awada A, Lalmand MC, Laporte M, Van Den Heule B, Verhest A, Pochet R, Heenen M. Vereecken P, et al. Among authors: awada a. Arch Dermatol Res. 2005 Feb;296(8):353-8. doi: 10.1007/s00403-004-0536-6. Epub 2005 Jan 11. Arch Dermatol Res. 2005. PMID: 15645276

7

[Topical photodynamic therapy in cutaneous oncology].

Vereecken P, Laporte M, Awada A, Velu T, Heenen M. Vereecken P, et al. Among authors: awada a. Rev Med Brux. 2004 Dec;25(6):512-20. Rev Med Brux. 2004. PMID: 15688890 Review. French.

8

[Re: innovative therapeutic approaches in melanoma].

Vereecken P, Awada A, Devriendt D, Laporte M, Heenen M, Salès F, Cappello M. Vereecken P, et al. Among authors: awada a. Rev Med Brux. 2004 Dec;25(6):S 542. Rev Med Brux. 2004. PMID: 15688894 French. No abstract available.

9

Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumours.

Awada A, Hendlisz A, Gil T, Bartholomeus S, Mano M, de Valeriola D, Strumberg D, Brendel E, Haase CG, Schwartz B, Piccart M. Awada A, et al. Br J Cancer. 2005 May 23;92(10):1855-61. doi: 10.1038/sj.bjc.6602584. Br J Cancer. 2005. PMID: 15870716 Free PMC article. Clinical Trial.

10

High serum galectin-3 in advanced melanoma: preliminary results.

Vereecken P, Zouaoui Boudjeltia K, Debray C, Awada A, Legssyer I, Sales F, Petein M, Vanhaeverbeek M, Ghanem G, Heenen M. Vereecken P, et al. Among authors: awada a. Clin Exp Dermatol. 2006 Jan;31(1):105-9. doi: 10.1111/j.1365-2230.2005.01992.x. Clin Exp Dermatol. 2006. PMID: 16309497

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

546 results

Search Page